National

Hunter Biden loses bid to toss tax evasion case

Aug 20, 2024

Washington [US], August 20: A judge denied a bid by U.S. President Joe Biden's son, Hunter, to dismiss a federal tax evasion case brought against him in California.
Hunter Biden was convicted in Delaware in June for lying about his illegal drug use to buy a gun, and is scheduled to go to trial in September in the tax evasion case.
Biden, who has pleaded not guilty to the tax charges, had argued that David Weiss, the special counsel leading both prosecutions, was illegally appointed.
The president's son had relied on a federal judge's decision dismissing a criminal case accusing former President Donald Trump of illegally retaining classified documents after leaving office.
Florida-based U.S. District Judge Aileen Cannon found the appointment of the special counsel in that case, Jack Smith, violated the U.S. Constitution because Congress had not given him the authority to pursue the case.
Smith's office is appealing.
But U.S. District Judge Mark Scarsi in Los Angeles said on Monday there was no valid basis to reconsider a prior order denying Hunter Biden's bid to throw out the tax evasion indictment.
"The court declines to reach the merits of the motion because there is no valid basis for reconsideration of the court's order denying Mr. Biden's motion to dismiss," the judge wrote.
Source: Fijian Broadcasting Corporation

More news

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Mumbai (Maharashtra) [India]/ Iselin (New Jersey) [US], July 10: Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment--without hindering innovation. Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation.

Jul 10, 2025